Screener
Acadia Pharmaceuticals ACAD Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Acadia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The source filing: Acadia Pharmaceuticals’s 10-Q, filed August 5, 2026.
- Filed
- Aug 4, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333243
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Prepaid expenses and other current assets | 69,369 | 59,526 |
| Total current assets | 1,224,545 | 1,062,113 |
| Property and equipment, net | 17,107 | 7,511 |
| Operating lease right-of-use assets | 69,424 | 47,354 |
| Intangible assets, net | 103,448 | 108,893 |
| Restricted cash | 7,846 | 7,845 |
| Long-term inventory | 76,301 | 76,704 |
| Deferred tax assets | 240,679 | 249,879 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Acadia Pharmaceuticals's operating lease ROU assets?
- Acadia Pharmaceuticals (ACAD) reported operating lease ROU assets of $69.42M in Q2 2026.
- How has Acadia Pharmaceuticals's operating lease ROU assets changed year-over-year?
- Acadia Pharmaceuticals's operating lease ROU assets increased by 36.1% year-over-year, from $50.99M to $69.42M.
- What is the long-term trend for Acadia Pharmaceuticals's operating lease ROU assets?
- Over 5 years (2020 to 2025), Acadia Pharmaceuticals's operating lease ROU assets has grown at a 0.0% compound annual growth rate (CAGR), from $47.28M to $47.35M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.
Ask your AI about Acadia Pharmaceuticals's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude